Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

• Status: Completed
• Trial end date: 2004-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved cholesterol lowering medication.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Ezetimibe

Criteria

Inclusion Criteria:

• Patients with elevated cholesterol and coronary heart disease

Exclusion Criteria:

• Patients who have cholesterol levels within normal ranges as identified by the study